Letter to the Editor: No Evidence to Promote Interim FDG-PET Adapted Therapy in the NCCN Guidelines for Hodgkin Lymphoma

被引:3
作者
Adams, Hugo J. A. [1 ]
Kwee, Thomas C. [2 ]
机构
[1] Deventer Hosp, Deventer, Netherlands
[2] Univ Groningen, Univ Med Ctr Groningen, Groningen, Netherlands
来源
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK | 2018年 / 16卷 / 03期
关键词
METAANALYSIS;
D O I
10.6004/jnccn.2018.7011
中图分类号
R73 [肿瘤学];
学科分类号
100214 [肿瘤学];
摘要
引用
收藏
页码:226 / 227
页数:2
相关论文
共 9 条
[1]
Controversies on the prognostic value of interim FDG-PET in advanced-stage Hodgkin lymphoma [J].
Adams, Hugo J. A. ;
Kwee, Thomas C. .
EUROPEAN JOURNAL OF HAEMATOLOGY, 2016, 97 (06) :491-498
[2]
Proportion of false-positive lesions at interim and end-of-treatment FDG-PET in lymphoma as determined by histology: Systematic review and meta-analysis [J].
Adams, Hugo J. A. ;
Kwee, Thomas C. .
EUROPEAN JOURNAL OF RADIOLOGY, 2016, 85 (11) :1963-1970
[3]
Will treatment intensification in early-stage Hodgkin lymphoma patients with a positive interim FDG-PET improve outcome? [J].
Adams, Hugo J. A. ;
Kwee, Thomas C. .
PEDIATRIC HEMATOLOGY AND ONCOLOGY, 2016, 33 (01) :1-4
[4]
Systematic review and meta-analysis on the prognostic value of complete remission status at FDG-PET in Hodgkin lymphoma after completion of first-line therapy [J].
Adams, Hugo J. A. ;
Nievelstein, Rutger A. J. ;
Kwee, Thomas C. .
ANNALS OF HEMATOLOGY, 2016, 95 (01) :1-9
[5]
Opportunities and limitations of bone marrow biopsy and bone marrow FDG-PET in lymphoma [J].
Adams, Hugo J. A. ;
Nievelstein, Rutger A. J. ;
Kwee, Thomas C. .
BLOOD REVIEWS, 2015, 29 (06) :417-425
[6]
Progression-free survival of early interim PET-positive patients with advanced stage Hodgkin's lymphoma treated with BEACOPPescalated alone or in combination with rituximab (HD18): an open-label, international, randomised phase 3 study by the German Hodgkin Study Group [J].
Borchmann, Peter ;
Haverkamp, Heinz ;
Lohri, Andreas ;
Mey, Ulrich ;
Kreissl, Stefanie ;
Greil, Richard ;
Markova, Jana ;
Feuring-Buske, Michaela ;
Meissner, Julia ;
Duehrsen, Ulrich ;
Ostermann, Helmut ;
Keller, Ulrich ;
Maschmeyer, Georg ;
Kuhnert, Georg ;
Dietlein, Markus ;
Kobe, Carsten ;
Eich, Hans ;
Baues, Christian ;
Stein, Harald ;
Fuchs, Michael ;
Diehl, Volker ;
Engert, Andreas .
LANCET ONCOLOGY, 2017, 18 (04) :454-463
[7]
Hodgkin Lymphoma Version 1.2017 [J].
Hoppe, Richard T. ;
Advani, Ranjana H. ;
Ai, Weiyun Z. ;
Ambinder, Richard F. ;
Aoun, Patricia ;
Bello, Celeste M. ;
Benitez, Cecil M. ;
Bernat, Karl ;
Bierman, Philip J. ;
Blum, Kristie A. ;
Chen, Robert ;
Dabaja, Bouthaina ;
Forero, Andres ;
Gordon, Leo I. ;
Hernandez-Ilizaliturri, Francisco J. ;
Hochberg, Ephraim P. ;
Huang, Jiayi ;
Johnston, Patrick B. ;
Kaminski, Mark S. ;
Kenkre, Vaishalee P. ;
Khan, Nadia ;
Maloney, David G. ;
Mauch, Peter M. ;
Metzger, Monika ;
Moore, Joseph O. ;
Morgan, David ;
Moskowitz, Craig H. ;
Mulroney, Carolyn ;
Poppe, Matthew ;
Rabinovitch, Rachel ;
Seropian, Stuart ;
Smith, Mitchell ;
Winter, Jane N. ;
Yahalom, Joachim ;
Burns, Jennifer ;
Ogba, Ndiya ;
Sundar, Hema .
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2017, 15 (05) :608-638
[8]
Hodgkin's lymphoma: the pathologist's viewpoint [J].
Pileri, SA ;
Ascani, S ;
Leoncini, L ;
Sabattini, E ;
Zinzani, PL ;
Piccaluga, PP ;
Pileri, A ;
Giunti, M ;
Falini, B ;
Bolis, GB ;
Stein, H .
JOURNAL OF CLINICAL PATHOLOGY, 2002, 55 (03) :162-176
[9]
PET-adapted omission of radiotherapy in early stage Hodgkin lymphoma-a systematic review and meta-analysis [J].
Sickinger, Marie T. ;
von Tresckow, Bastian ;
Kobe, Carsten ;
Borchmann, Peter ;
Engert, Andreas ;
Skoetz, Nicole .
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2016, 101 :86-92